← Back to Search

Behavioral Intervention

Interval Training for Parkinson's Disease

N/A
Recruiting
Led By Joseph F. Signorile, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 30-90 years of age
Confirmed diagnosis of Parkinson's disease
Must not have
Documented HIV infection or another immunodeficiency syndrome
Other neuromuscular diseases besides Parkinson's disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 10 weeks
Awards & highlights
No Placebo-Only Group

Summary

"This trial is comparing the effects of high-intensity interval training and high-velocity circuit resistance training on heart rate variability, walking, and overall physical function in Parkinson's disease patients."

Who is the study for?
This trial is for individuals with Parkinson's Disease, specifically those who have issues with their autonomic nervous system. The exact eligibility criteria are not provided, but typically participants should be medically stable to engage in physical training.
What is being tested?
The study compares two exercise approaches: high-intensity interval training (short bursts of intense exercise) and high-velocity circuit resistance training (strength exercises at a fast pace), focusing on their effects on heart rate variability, walking ability, and overall function.
What are the potential side effects?
While specific side effects are not listed for the interventions being tested, general risks may include muscle soreness, fatigue, joint stress or injury from physical activity. Participants' safety will be monitored throughout.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 90 years old.
Select...
I have been diagnosed with Parkinson's disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have HIV or another immune system condition.
Select...
I have a neuromuscular condition that is not Parkinson's disease.
Select...
I have an injury that stops me from exercising.
Select...
I have a heart condition that stops me from joining a training program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in Cadence of Gait
Changes in Double Support time of Gait
Changes in Heart Rate Recovery
+13 more
Secondary study objectives
Changes in the Parkinson's Disease Questionnaire-39
Non-Motor Symptoms Scale for Parkinson's Disease

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-Intensity Interval TrainingExperimental Treatment1 Intervention
Participants in this group will receive high-intensity interval training 2 times per week for 10 consecutive weeks.
Group II: High-Velocity Circuit Resistance TrainingActive Control1 Intervention
Participants in this group will receive high-velocity circuit resistance training 2 times per week for 10 consecutive weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High-Intensity Interval Training
2019
Completed Phase 2
~790

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
949 Previous Clinical Trials
428,417 Total Patients Enrolled
Joseph F. Signorile, PhDPrincipal InvestigatorUniversity of Miami
4 Previous Clinical Trials
202 Total Patients Enrolled
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top